Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AdaptHealth Corp.AHCO · Entity 5183 | Chief Financial Officer | November 08, 2019 | November 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AdaptHealth Corp.
Report date November 08, 2019 · Filed November 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 104,486 |
Reported balance
After 2019-11-08 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2019-11-08 · Other · Acquired 104,486 · Balance 104,486 F1: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F2: Securities held directly by Wheatfield LLC. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 688,334 |
Reported balance
After 2019-11-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-11-08 · Grant · Acquired 688,334 · Balance 688,334 F3: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date. F2: Securities held directly by Wheatfield LLC. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | IndirectSee Footnote | 33,348 |
Reported balance
After 2019-11-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-11-08 · Other · Acquired 33,348 · Balance 33,348 F1: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F4: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F2: Securities held directly by Wheatfield LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC.
F2: Securities held directly by Wheatfield LLC.
F3: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date.
F4: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2019 Filed Nov 13, 2019 21:19 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherWarrants · Derivative | 33,348 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-19-063544 · a4.xml · derivative · entry 3 Holst Gregg A · CIK 0001347931 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 33,348 Underlying: Class A Common Stock · 33,348 shares Expires not disclosed F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F4 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F4 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F2 · ownership.nature: Securities held directly by Wheatfield LLC. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 21:19 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass B Common Stock · Derivative | 688,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-063544 · a4.xml · derivative · entry 2 Holst Gregg A · CIK 0001347931 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 688,334 Underlying: Class A Common Stock · 688,334 shares Expires not disclosed F3 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date. F3 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date. F3 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date. F3 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 354,988 of the common units of AdaptHealth Holdings LLC are subject to vesting, with 177,494 units vesting on May 17, 2020 and 88,747 units vesting on each of the first two anniversaries of such date. F2 · ownership.nature: Securities held directly by Wheatfield LLC. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 21:19 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherClass A Common Stock | 104,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-063544 · a4.xml · nonDerivative · entry 1 Holst Gregg A · CIK 0001347931 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 104,486 F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F2 · ownership.nature: Securities held directly by Wheatfield LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.